State
of New York
|
1-10113
|
11-0853640
|
(State
of Other Jurisdiction
|
Commission
File Number)
|
(I.R.S.
Employer
|
of
Incorporation)
|
Identification
Number)
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17CFR240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR
240.13e-4(c))
|
Nominee
|
For
|
Withheld
|
Abstentions
|
Broker
Non-Votes
|
Richard
J. Markham
|
34,233,096
|
0
|
382,633
|
6,972,553
|
Andrew
D. Reddick
|
34,325,736
|
0
|
289,993
|
6,972,553
|
William
A. Sumner
|
34,552,537
|
0
|
63,192
|
6,972,553
|
Bruce
F. Wesson
|
34,231,996
|
0
|
383,733
|
6,972,553
|
William
G. Skelly
|
34,555,075
|
0
|
60,654
|
6,972,553
|
Immanuel
Thangaraj
|
34,231,946
|
0
|
383,783
|
6,972,553
|
George
K. Ross
|
34,556,007
|
0
|
59,722
|
6,972,553
|
For
|
Against
|
Abstentions
|
Broker
Non-Votes
|
41,547,968
|
40,308
|
6
|
0
|
ACURA PHARMACEUTICALS, INC. | |||
Date:
May 21, 2010
|
By:
|
/s/ Peter A. Clemens | |
Peter A. Clemens | |||
Senior Vice President & Chief Financial Officer | |||